Results 11 to 20 of about 281,799 (312)

Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder. [PDF]

open access: yes, 2019
BackgroundRepetitive Transcranial Magnetic Stimulation (rTMS) is commonly administered to Major Depressive Disorder (MDD) patients taking psychotropic medications, yet the effects on treatment outcomes remain unknown.
Chawla, Shweta A   +7 more
core   +1 more source

Recent Advancement in Drug Design and Discovery of Pyrazole Biomolecules as Cancer and Inflammation Therapeutics

open access: yesMolecules, 2022
Pyrazole, an important pharmacophore and a privileged scaffold of immense significance, is a five-membered heterocyclic moiety with an extensive therapeutic profile, viz., anti-inflammatory, anti-microbial, anti-anxiety, anticancer, analgesic ...
Md. Jahangir Alam   +10 more
doaj   +1 more source

Incidence and drug treatment of emotional distress after cancer diagnosis : a matched primary care case-control study [PDF]

open access: yes, 2012
Notes This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License.Peer ...
A J Lee   +33 more
core   +1 more source

Evaluation of Depression and Anxiety Disorders and Correlation with the Treatment of Patients with Psoriasis Vulgaris

open access: yesRevista da Sociedade Portuguesa de Dermatologia e Venereologia, 2020
Introduction: Psoriasis is a chronic inflammatory multisystemic disease with several comorbidities, namely anxiety and depression disorders. Methods: In this study, the prevalence of these psychiatric entities was investigated by the PHQ-9 and GAD-7 ...
Adriana Kamilly Leitão Pitman Machado   +4 more
doaj   +1 more source

Medication use by early-stage breast cancer survivors: a 1-year longitudinal study. [PDF]

open access: yes, 2016
PurposeThe aim of this study is to characterize the patterns of medication use by early-stage breast cancer (ESBC) survivors from diagnosis to 1 year post-chemotherapy.MethodsA single-center longitudinal study was conducted with ESBC patients diagnosed ...
Chan, Alexandre   +4 more
core   +1 more source

Comparison of Oral Midazolam and Promethazine with Oral Midazolam alone for Sedating Children during Computed Tomography

open access: yesArchives of Academic Emergency Medicine, 2018
Introduction: Both midazolam and promethazine are recommended to be used as sedatives in many studies but each have some side effects that limits their use. Combination therapy as an alternative method, may decreases these limitations.
Hassan Barzegari   +5 more
doaj   +1 more source

Comparing the Sedative Effects of Intranasal Dexmedetomidine, Midazolam, and Ketamine in Outpatient Pediatric Surgeries: A Randomized Clinical Trial [PDF]

open access: yesIranian Journal of Medical Sciences
Background: The management of preoperative anxiety in pediatric patients, as well as its implications, has remained challenging for anesthesiologists.
Simin Azemati   +6 more
doaj   +1 more source

Insights into the neuroprotective properties of Biochanin-A

open access: yesArchives of Pharmaceutical Sciences Ain Shams University, 2022
The global morbidity and mortality caused by neurological disorders are significant. Neurodegenerative disorders are anticipated to rise as the population ages because they typically manifest in mid-to-late life.
Sarah Hussein   +3 more
doaj   +1 more source

“Software agents and haunted media : the twitter bot as political actor" [PDF]

open access: yes, 2018
This report examines the rhetorical construction of Twitter bots as nonhuman political agents in press coverage of the 2016 U.S. election. It takes the rhetorical framing of “the Twitter bot” as a case study to argue that Twitter bots are a contemporary ...
Colclough, Sarah Ansley
core   +1 more source

Cannabidiol prescription in clinical practice: an audit on the first 400 patients in New Zealand

open access: yesBJGP Open, 2020
Background: Cannabidiol (CBD) is the non-euphoriant component of cannabis. In 2017, the New Zealand Misuse of Drugs Regulations (1977) were amended, allowing doctors to prescribe CBD. Therapeutic benefit and tolerability of CBD remains unclear.
Graham Gulbransen   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy